supp.fit

Aveta Biomics

Aveta Biomics develops APG-157, an oral immunotherapy designed to reprogram the tumor immune microenvironment in head and neck cancer and glioblastoma.

1 product in our catalogue.

avetabiomics.com
Products
1

Products we hold for this brand, not the size of the company.

Categories
1

Distinct product categories these listings fall into.

Median price
$13.99

Half its products cost less than this, half cost more.

Products

Most sold first, by monthly units in our Amazon snapshot.